BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 150 filers reported holding BIODELIVERY SCIENCES INTL IN in Q3 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,555,000 | -13.5% | 370,230 | -23.2% | 0.70% | -33.3% |
| Q3 2020 | $1,798,000 | -18.4% | 481,930 | -4.7% | 1.06% | -12.3% |
| Q2 2020 | $2,204,000 | +15.0% | 505,530 | 0.0% | 1.20% | -0.5% |
| Q1 2020 | $1,916,000 | -39.9% | 505,530 | +0.2% | 1.21% | -6.5% |
| Q4 2019 | $3,189,000 | +46.4% | 504,607 | -2.5% | 1.29% | +41.3% |
| Q3 2019 | $2,179,000 | +3.5% | 517,507 | +14.3% | 0.92% | +3.0% |
| Q2 2019 | $2,106,000 | -0.8% | 452,802 | +13.1% | 0.89% | +5.0% |
| Q1 2019 | $2,123,000 | +14.7% | 400,500 | -19.9% | 0.85% | -2.8% |
| Q4 2018 | $1,851,000 | +76.8% | 500,300 | +33.8% | 0.87% | +155.9% |
| Q3 2018 | $1,047,000 | +70.5% | 374,000 | +79.8% | 0.34% | +47.8% |
| Q2 2018 | $614,000 | +127.4% | 208,000 | +73.3% | 0.23% | +107.2% |
| Q1 2018 | $270,000 | – | 120,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,595,855 | $10,929,000 | 10.61% |
| Broadfin Capital, LLC | 4,300,066 | $18,103,000 | 3.35% |
| 1492 Capital Management LLC | 778,483 | $3,277,000 | 3.20% |
| Avoro Capital Advisors LLC | 7,424,867 | $31,259,000 | 1.30% |
| Rubric Capital Management LP | 2,590,288 | $10,905,000 | 1.00% |
| Eversept Partners, LP | 708,020 | $2,980,764 | 0.92% |
| KNOTT DAVID M | 517,507 | $2,179,000 | 0.92% |
| Nantahala Capital Management | 4,846,167 | $20,402,000 | 0.76% |
| Grandeur Peak Global Advisors, LLC | 1,180,075 | $4,968,000 | 0.54% |
| EMERALD ADVISERS, LLC | 2,084,685 | $8,777,000 | 0.41% |